209 related articles for article (PubMed ID: 30205050)
1. Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner.
Mancini A; Xavier-Magalhães A; Woods WS; Nguyen KT; Amen AM; Hayes JL; Fellmann C; Gapinske M; McKinney AM; Hong C; Jones LE; Walsh KM; Bell RJA; Doudna JA; Costa BM; Song JS; Perez-Pinera P; Costello JF
Cancer Cell; 2018 Sep; 34(3):513-528.e8. PubMed ID: 30205050
[TBL] [Abstract][Full Text] [Related]
2. Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Bell RJ; Rube HT; Kreig A; Mancini A; Fouse SD; Nagarajan RP; Choi S; Hong C; He D; Pekmezci M; Wiencke JK; Wrensch MR; Chang SM; Walsh KM; Myong S; Song JS; Costello JF
Science; 2015 May; 348(6238):1036-9. PubMed ID: 25977370
[TBL] [Abstract][Full Text] [Related]
3. Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer.
Barger CJ; Suwala AK; Soczek KM; Wang AS; Kim MY; Hong C; Doudna JA; Chang SM; Phillips JJ; Solomon DA; Costello JF
Nat Commun; 2022 Sep; 13(1):5430. PubMed ID: 36114166
[TBL] [Abstract][Full Text] [Related]
4. Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volume.
Aquilanti E; Kageler L; Watson J; Baird DM; Jones RE; Hodges M; Szegletes ZM; Doench JG; Strathdee CA; Figueroa JRMF; Ligon KL; Beck M; Wen PY; Meyerson M
Neuro Oncol; 2023 Jul; 25(7):1275-1285. PubMed ID: 36694348
[TBL] [Abstract][Full Text] [Related]
5. TERT promoter alterations could provide a solution for Peto's paradox in rodents.
Vedelek B; Maddali AK; Davenova N; Vedelek V; Boros IM
Sci Rep; 2020 Nov; 10(1):20815. PubMed ID: 33257697
[TBL] [Abstract][Full Text] [Related]
6. TPP1 promoter mutations cooperate with TERT promoter mutations to lengthen telomeres in melanoma.
Chun-On P; Hinchie AM; Beale HC; Gil Silva AA; Rush E; Sander C; Connelly CJ; Seynnaeve BKN; Kirkwood JM; Vaske OM; Greider CW; Alder JK
Science; 2022 Nov; 378(6620):664-668. PubMed ID: 36356143
[TBL] [Abstract][Full Text] [Related]
7. Hyperpolarized δ-[1-
Minami N; Hong D; Taglang C; Batsios G; Gillespie AM; Viswanath P; Stevers N; Barger CJ; Costello JF; Ronen SM
Sci Rep; 2023 Mar; 13(1):5190. PubMed ID: 36997627
[TBL] [Abstract][Full Text] [Related]
8. Understanding TERT Promoter Mutations: A Common Path to Immortality.
Bell RJ; Rube HT; Xavier-Magalhães A; Costa BM; Mancini A; Song JS; Costello JF
Mol Cancer Res; 2016 Apr; 14(4):315-23. PubMed ID: 26941407
[TBL] [Abstract][Full Text] [Related]
9. Integrated evaluation of telomerase activation and telomere maintenance across cancer cell lines.
Hu K; Ghandi M; Huang FW
Elife; 2021 Sep; 10():. PubMed ID: 34486523
[TBL] [Abstract][Full Text] [Related]
10. Pooled genetic screens to identify vulnerabilities in TERT-promoter-mutant glioblastoma.
Tu KJ; Stewart CE; Hendrickson PG; Regal JA; Kim SY; Ashley DM; Waitkus MS; Reitman ZJ
Oncogene; 2023 Oct; 42(44):3274-3286. PubMed ID: 37741952
[TBL] [Abstract][Full Text] [Related]
11. Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastoma.
Minami N; Hong D; Stevers N; Barger CJ; Radoul M; Hong C; Chen L; Kim Y; Batsios G; Gillespie AM; Pieper RO; Costello JF; Viswanath P; Ronen SM
Neuro Oncol; 2022 Nov; 24(11):1898-1910. PubMed ID: 35460557
[TBL] [Abstract][Full Text] [Related]
12. E4F1 and ZNF148 are transcriptional activators of the -57A > C and wild-type
Chua BH; Zaal Anuar N; Ferry L; Domrane C; Wittek A; Mukundan VT; Jha S; Butter F; Tenen DG; Defossez PA; Kappei D
Genome Res; 2023 Nov; 33(11):1893-905. PubMed ID: 37918959
[TBL] [Abstract][Full Text] [Related]
13. NFκB drives TERT promoter reactivation in cancer.
Tergaonkar V
Cell Cycle; 2016; 15(2):156-7. PubMed ID: 26588470
[No Abstract] [Full Text] [Related]
14. Correction to: Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression.
Neuro Oncol; 2024 May; 26(5):982. PubMed ID: 38345188
[No Abstract] [Full Text] [Related]
15. Programmed DNA destruction by miniature CRISPR-Cas14 enzymes.
Harrington LB; Burstein D; Chen JS; Paez-Espino D; Ma E; Witte IP; Cofsky JC; Kyrpides NC; Banfield JF; Doudna JA
Science; 2018 Nov; 362(6416):839-842. PubMed ID: 30337455
[TBL] [Abstract][Full Text] [Related]
16. DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.
Lee DD; Leão R; Komosa M; Gallo M; Zhang CH; Lipman T; Remke M; Heidari A; Nunes NM; Apolónio JD; Price AJ; De Mello RA; Dias JS; Huntsman D; Hermanns T; Wild PJ; Vanner R; Zadeh G; Karamchandani J; Das S; Taylor MD; Hawkins CE; Wasserman JD; Figueiredo A; Hamilton RJ; Minden MD; Wani K; Diplas B; Yan H; Aldape K; Akbari MR; Danesh A; Pugh TJ; Dirks PB; Castelo-Branco P; Tabori U
J Clin Invest; 2019 Jan; 129(1):223-229. PubMed ID: 30358567
[TBL] [Abstract][Full Text] [Related]
17. GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.
Guo Y; Yuan X; Li K; Dai M; Zhang L; Wu Y; Sun C; Chen Y; Cheng G; Liu C; Strååt K; Kong F; Zhao S; Bjorkhölm M; Xu D
Cell Death Differ; 2020 Jun; 27(6):1862-1877. PubMed ID: 31802036
[TBL] [Abstract][Full Text] [Related]
18. Cancer-specific loss of
Amen AM; Fellmann C; Soczek KM; Ren SM; Lew RJ; Knott GJ; Park JE; McKinney AM; Mancini A; Doudna JA; Costello JF
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33758097
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for AcrVA4 inhibition of specific CRISPR-Cas12a.
Knott GJ; Cress BF; Liu JJ; Thornton BW; Lew RJ; Al-Shayeb B; Rosenberg DJ; Hammel M; Adler BA; Lobba MJ; Xu M; Arkin AP; Fellmann C; Doudna JA
Elife; 2019 Aug; 8():. PubMed ID: 31397669
[TBL] [Abstract][Full Text] [Related]
20. Evolutionary Trajectories of IDH
Körber V; Yang J; Barah P; Wu Y; Stichel D; Gu Z; Fletcher MNC; Jones D; Hentschel B; Lamszus K; Tonn JC; Schackert G; Sabel M; Felsberg J; Zacher A; Kaulich K; Hübschmann D; Herold-Mende C; von Deimling A; Weller M; Radlwimmer B; Schlesner M; Reifenberger G; Höfer T; Lichter P
Cancer Cell; 2019 Apr; 35(4):692-704.e12. PubMed ID: 30905762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
